• Mashup Score: 1
    Using OCT to identify biomarkers of early DR - 11 month(s) ago

    Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice from leading clinicians and other experts on managing the successful retina practice.

    Source: www.retina-specialist.com
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RetSpecMag
      RetSpecMag

      Using OCT to identify biomarkers of early DR Exploring the potential of OCT to evaluate photoreceptor health before signs and symptoms of diabetic retinopathy manifest. Read in the May/June issue or at https://t.co/kHHwdAkHae #retina #retinaspecialist #diabeticretinopathy #dme https://t.co/1CrG1b4Kxt

  • Mashup Score: 0
    Using OCT to identify biomarkers of early DR - 11 month(s) ago

    Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice from leading clinicians and other experts on managing the successful retina practice.

    Source: www.retina-specialist.com
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RetSpecMag
      RetSpecMag

      Using OCT to identify biomarkers of early DR Exploring the potential of optical coherence tomography to evaluate photoreceptor health before signs and symptoms of diabetic retinopathy manifest. https://t.co/TbESlVB3qM #diabeticretinopathy #retinopathy #retina #retinaspecialist https://t.co/HwZwOYLeuE

  • Mashup Score: 0
    Diabetic Retinopathy and Machine Learning - 1 year(s) ago

    Investigators created and validated code-free automated deep learning models (autoML) for diabetic retinopathy classification from handheld-camera retinal images.A total of 17,829 de-identified retinal images from 3,566 eyes with diabetes acquired using handheld retinal cameras in a community-based DR screening program were included.AutoML models were generated based on previously acquired…

    Source: www.reviewofophthalmology.com
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RevOphth
      RevOphth

      Diabetic Retinopathy and Machine Learning Investigators created and validated code-free automated deep learning models for diabetic retinopathy classification from handheld-camera retinal images. https://t.co/obCIBsnfw2 #diabeticretinopathy #retinopathy #retina #ophthalmology https://t.co/Znp06ERo2K

  • Mashup Score: 0
    Retinal Physician - SUBSPECIALTY NEWS: Early anti-VEGF for DR shows no benefit, developments in gene therapy, research on IRD, and more. - 1 year(s) ago

    Mount Sinai Study Could Lead to Early Diagnosis and Treatment of AMD ■ Two separate eye diseases — drusen and subretinal drusenoid deposits (SDDs) — may contribute to age-related macular degeneration (AMD), according to a new study from New York Eye and Ear Infirmary of Mount Sinai. “For the first time, we were able to measure autofluorescence, with ultrasensitive detectors to study advanced…

    Source: Retinal Physician
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RetinalPhys
      RetinalPhys

      Ocular Therapeutix announced interim 10-month data from its phase 1 clinical trial evaluating OTX-TKI, an axitinib intravitreal hydrogel implant in development for the treatment of #wetAMD, #diabeticretinopathy, and other retinal diseases. https://t.co/6r7ntxteGZ #ophthalmology https://t.co/x2jbZnFghm

  • Mashup Score: 0
    Ophthalmology Management - OPHTHALMOLOGY MANAGEMENT 40 UNDER 40 - 1 year(s) ago

    Earlier this year, we asked you, our readers, for nominations for our inaugural 40 Under 40 list. The goal was to highlight the next generation of ophthalmology: 40 ophthalmologists under 40 years old who have achieved excellence in their field. You responded with more than 100 nominations, detailing the efforts by many young surgeons in research, innovation, leadership, teaching,…

    Source: Ophthalmology Management
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of Ophthalmologymg
      Ophthalmologymg

      This week, we highlight @RoomasaC, assistant professor at @UWMadison_Eyes and a leader in the moonshot effort funded by JDRF and The Mary Tyler Moore foundation to create a new staging system for diabetic retinal disease. https://t.co/lNniEnf2Y6. #diabeticretinopathy #eyecare https://t.co/UXPuaF9n2x

  • Mashup Score: 0
    Omega-3s and Diabetic Retinopathy - 1 year(s) ago

    Inflammation is associated with diabetic retinopathy development and progression, and previous studies have demonstrated that omega-3 polyunsaturated fatty acids (PUFAs) have anti-inflammatory properties. Therefore, investigators say that the goal of their study was to determine if omega-3 PUFAs, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) were associated with decreased risk and…

    Source: www.reviewofophthalmology.com
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RevOphth
      RevOphth

      Omega-3s and Diabetic Retinopathy 🐟 Investigators found that docosahexaenoic acid (DHA) was inversely associated with presence and severity of diabetic retinopathy. https://t.co/7fuo3CaBz4 #retina #ophthalmology #retinopathy #diabeticretinopathy #type2diabetes #eyecare https://t.co/vbTiI6OQVh

  • Mashup Score: 0
    Retinal Physician - March 2023 - 1 year(s) ago

    Advertisement For this month’s Retina Minute, I have the pleasure of interviewing my dear friend, Peter K Kaiser, MD. Peter is the Chaney Family Endowed Chair in Ophthalmology Research, Professor of Ophthalmology, Cleveland Clinic Lerner…

    Source: Retinal Physician
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RetinalPhys
      RetinalPhys

      Potential Wide Use for Ocuphire’s APX-3330: An Oral Drug to Prevent #DiabeticRetinopathy Progression—Results of the Phase 2 ZETA-1 Trial, by Peter K Kaiser, MD, and Michael Singer, MD https://t.co/aixIzvh6p4 #ophthalmology https://t.co/TjrS8FF24O

Load More